SEB Bioteknikfond D vs UBS Lux Equity Fund Biotech USD
1. SEB Bioteknikfond D
2. UBS Lux Equity Fund Biotech USD
Fund Holdings
We have information about 24 holdings in SEB Bioteknikfond D, where the largest holding is Gilead Sciences (10.04), followed by Vertex (8.8) and Amgen (8.54). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).
All Holdings
Here we compare the holdings in SEB Bioteknikfond D and UBS Lux Equity Fund Biotech USD.
SEB Bioteknikfond D |
UBS Lux Equity Fund Biotech USD |
1. Gilead Sciences Inc  10.04 % |
1. Regeneron Pharmaceuticals Inc 10.04 % |
2. Vertex Pharmaceuticals Inc 8.8 % |
2. Vertex Pharmaceuticals Inc 9.9 % |
3. Amgen Inc 8.54 % |
3. Moderna Inc 9.21 % |
4. Regeneron Pharmaceuticals Inc 5.09 % |
4. Alnylam Pharmaceuticals Inc 6.54 % |
5. Alnylam Pharmaceuticals Inc 5.07 % |
5. AbbVie Inc  5.52 % |
6. AstraZeneca ADR  4.49 % |
6. Gilead Sciences Inc  4.66 % |
7. Verona Pharma ADR 3.46 % |
7. Amgen Inc 4.32 % |
8. Argenx ADR 2.72 % |
8. BioNTech SE 4.13 % |
9. Illumina Inc 2.72 % |
9. Karuna Therapeutics Inc 3.75 % |
10. BioNTech SE 2.41 % |
10. Royalty Pharma Plc 3.28 % |
11. Madrigal Pharmaceuticals Inc 1.88 % |
- |
12. BoneSupport AB  1.82 % |
- |
13. BioMarin Pharmaceutical Inc 1.7 % |
- |
14. Krystal Biotech Inc 1.48 % |
- |
15. NewAmsterdam Pharma NV 1.46 % |
- |
16. BridgeBio Pharma Inc 1.45 % |
- |
17. Cytokinetics Inc 1.4 % |
- |
18. Ionis Pharmaceuticals Inc 1.37 % |
- |
19. Xenon Pharmaceuticals 1.37 % |
- |
20. Insmed Inc 1.32 % |
- |
21. Onward Medical NV 1.31 % |
- |
22. Janux Therapeutics Inc 1.3 % |
- |
23. Structure Therapeutics ADR 1.24 % |
- |
24. Kymera Therapeutics Inc 1.09 % |
- |
The list of fund holdings was last updated on April 17, 2025.